Biocryst Pharmaceuticals (BCRX) Work In Process (2015 - 2017)
Biocryst Pharmaceuticals' (BCRX) quarterly Work In Process came in at $1.3 million in Q2 2017, down 33.04% YoY from $1.9 million in Q2 2016, and up 99.24% on a QoQ basis from $655000.0 in Q1 2017.
Biocryst Pharmaceuticals (BCRX) Work In Process (2015 - 2017) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 3 years of Work In Process data on file, last reported at $1.3 million in Q2 2017.
- Quarterly Work In Process fell 33.04% year-over-year to $1.3 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $1.3 million (down 33.04% YoY) and the FY2016 annual result came in at $500000.0, down 68.98% from the prior year.
- Work In Process grew to $1.3 million in Q2 2017, from $655000.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $2.2 million in Q3 2016 to a low of $500000.0 in Q4 2016.
- A 3-year average of $1.5 million and a median of $1.6 million in 2015 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2016 — Work In Process slumped 68.98% — and 2017, when it plunged 33.04%.
- Tracing BCRX's Work In Process over 3 years: stood at $1.6 million in 2015, then plunged by 68.98% to $500000.0 in 2016, then jumped by 161.0% to $1.3 million in 2017.
- The last three Work In Process figures came in at $1.3 million (Q2 2017), $655000.0 (Q1 2017), and $500000.0 (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.36 Bn | 43.40 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.75 Bn | 40.09 Bn | 2.15 Bn |
| 3 | Zoetis | 32.42 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.93 Bn | 18.05 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 1.31 Mn |
| Mar 31, 2017 | 655,000.00 |
| Dec 31, 2016 | 500,000.00 |
| Sep 30, 2016 | 2.23 Mn |
| Jun 30, 2016 | 1.95 Mn |
| Mar 31, 2016 | 1.95 Mn |
| Dec 31, 2015 | 1.61 Mn |